Overactive Bladder

Vibegron (RVT-901/MK-4618/KRP-114V) Administered Once Daily as Monotherapy or Concomitantly with Tolterodine in Patients with an Overactive Bladder - Beyond the Abstract July 12, 2019

A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment - Beyond the Abstract May 14, 2019

Abdominal versus Standard Placement of the Sacral Nerve Stimulator Implantable Pulse Generator - Beyond the Abstract March 7, 2019

A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, Design, and Methodology– Beyond the Abstract June 11, 2018

Association Between Coronary Artery Disease Severity and Overactive Bladder in Geriatric Patients: Beyond the Abstract October 27, 2017

Use of Third Line Therapy for Overactive Bladder in a Practice with Multiple Subspecialty Providers: Beyond the Abstract October 13, 2017

What is the true catheterization rate after intravesical onabotulinumtoxinA injection: Beyond the Abstract August 23, 2017

Real-Time Changes in Brain Activity During Sacral Neuromodulation for Overactive Bladder: Beyond the Abstract July 25, 2017

Impact of intravesical onabotulinumtoxinA on sexual function in women with OAB: Beyond the Abstract January 26, 2017

Readability Analysis of Online Health Information about Overactive Bladder: Beyond the Abstract January 18, 2017

Therapeutic potential of human chorionic gonadotropin against overactive bladder - Beyond the Abstract January 18, 2016

Real-World Patterns of Care for the Overactive Bladder (OAB) Syndrome in the United States - Beyond the Abstract October 15, 2015

Overactive bladder syndrome, detrusor overactivity and the botulinum toxin - Beyond the Abstract August 31, 2015

Refractory Overactive Bladder: A common problem? Beyond the Abstract August 27, 2015

Neuromodulation for Overactive Bladder Symptoms in Women Utilizing Either Motor or Sensory/Motor Provocation With a Minimum Nine-Year Follow-Up - Beyond the Abstract July 23, 2015

Solabegron: A potential future addition to the β-3 adrenoceptor agonist armamentarium for the management of overactive bladder, "Beyond the Abstract," by Pamela I. Ellsworth, MD, FACS May 14, 2015

Central inhibition of refractory overactive bladder complaints, results of an inpatient training program, "Beyond the Abstract," by Eelco F. J. Meijer, MD, MSc March 27, 2015

Intra-detrusor botox versus sacral neuromodulation for overactive bladder symptoms after unsuccessful anticholinergic treatment: Women's perspective, "Beyond the Abstract," by Pooja Balchandra July 28, 2014

Repeated botulinum toxin type A (Dysport®) injections for women with intractable detrusor overactivity, "Beyond the Abstract," by Angamuthu Arunkalaivanan July 25, 2014

Urethral calibration for the treatment of women with overactive bladder syndrome, "Beyond the Abstract," by Chao H. Chen, MD; Renee Sato, MD; Grace Matsuura, MPH; and David Wei, MD June 13, 2014

Page 1 of 3

Pelvic Health Weekly Newsletter